Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Cell Biochem. 2015 Sep 8;117(3):721–729. doi: 10.1002/jcb.25357

Figure 5. Effect of FGF-2 treatment on p-β-catenin and activated-β-catenin protein expression in human mesenchyme-derived progenitor cells.

Figure 5

Western blot analysis (A) and immunofluorescence staining (IF) (B, C) showed that p-β-catenin protein expression was higher in cells from an old (65yo) subject compared with a young (29yo). FGF-2 treatment resulted in a decrease in p-β-catenin in cells from both young and old subjects. In contrast, activated-β-catenin protein expression was lower in cells from the old subject compared with the young. FGF2 treatment resulted in an increase in activated-p-β-catenin in cells from both young and old subjects.